Transcat Receives 'Moderate Buy' Rating from Analysts

Got story updates? Submit your updates here. ›

Transcat, Inc. (NASDAQ:TRNS), a leading provider of calibration, laboratory, and metrology services in North America, has received a 'Moderate Buy' consensus rating from a group of five research analysts covering the firm, according to Marketbeat Ratings. The analysts' average 12-month price target for Transcat's stock is $105.33.

Why it matters

Transcat's 'Moderate Buy' rating from analysts suggests the company's stock is viewed as a potentially worthwhile investment, despite some mixed opinions. As a provider of critical measurement and compliance services, Transcat's performance is an important indicator of activity in industries it serves across North America.

The details

The analysts' ratings for Transcat include one 'sell' rating, one 'hold' rating, two 'buy' ratings, and one 'strong buy' rating. Weiss Ratings previously had a 'sell (d+)' rating on the stock, but Zacks Research has since raised its rating to 'hold'. Transcat's stock opened at $74.41 per share on Tuesday, with a 52-week range of $50.23 to $97.08.

• Transcat released its latest earnings report on February 3, 2026.
• The company's stock has a 12-month average price target of $105.33 from the analysts covering it.

What they’re saying